{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Development of Locally Applied Corticosteroid Products for the Short- Term Treatment of Symptoms Associated with Internal or External Hemorrhoids.\" This draft guidance will serve as a focus for continued discussions among the Division of Gastroenterology and Inborn Error Products, pharmaceutical sponsors, the academic community, and the public.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2019/12/09/2019-26464.html","cfr_references":[],"citation":"84 FR 67274","comment_url":null,"comments_close_on":"2020-02-07","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the draft guidance by February 7, 2020 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-D-4433"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":2,"comment_start_date":"2019-12-09","updated_at":"2023-02-28T13:54:31.207-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2019-D-4433-0001","allow_late_comments":null,"id":"FDA-2019-D-4433-0001","comment_end_date":"2020-02-08","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2019-D-4433","title":"Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with Internal or External Hemorrhoids; Draft Guidance for Industry; Availability"}],"document_number":"2019-26464","effective_on":null,"end_page":67275,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2019/12/09/2019-26464.xml","html_url":"https://www.federalregister.gov/documents/2019/12/09/2019-26464/development-of-locally-applied-corticosteroid-products-for-the-short-term-treatment-of-symptoms","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2019-26464?publication_date=2019-12-09","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2019-12-09/2019-26464/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":453,"last_updated":"2026-04-05 00:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2019-12-09/pdf/2019-26464.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2019-26464.pdf?1575639920","publication_date":"2019-12-09","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2019/12/09/2019-26464.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":2,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-D-4433","supporting_documents_count":0,"docket_id":"FDA-2019-D-4433","document_id":"FDA-2019-D-4433-0001","regulation_id_number":null,"title":"Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with Internal or External Hemorrhoids; Draft Guidance for Industry; Availability","checked_regulationsdotgov_at":"2023-02-28T18:54:30Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":67274,"subtype":null,"title":"Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated With Internal or External Hemorrhoids; Draft Guidance for Industry; Availability","toc_doc":"Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with Internal or External Hemorrhoids","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":84}